Organ-on-Chip Market Analysis and Forecast to 2031: By Type (Liver, Kidney, Lung, Others), Application (Toxicity Testing, Physiological Models, Others), End-User (Academic, Research Institute, Others), and Region
Organ-on-chip technology is a way to miniaturize organs and organ systems so that they can be studied in a laboratory setting. This technology can be used to study how organs and organ systems interact with each other, as well as how they respond to drugs and other treatments. Organ-on-chip systems can also be used to study diseases and to test new therapies.
Key Trends
Organ-on-Chip technology is an emerging field of research that aims to miniaturize and recreate functional organs and tissues on microchips. This technology has the potential to revolutionize the way we study disease, develop new therapeutics, and ultimately improve human health.
One of the key trends in Organ-on-Chip technology is the development of more complex and realistic models. Current models are often simplistic and do not accurately reflect the complexities of the human body.
Another key trend is the use of alternative materials to create Organ-on-Chips. The traditional material used to create these chips is silicon, but there is a growing interest in using other materials such as hydrogels and biopolymers.
Finally, there is a trend towards the development of multi-organ models. These models incorporate multiple organs and tissues on a single chip in order to more accurately simulate the human body.
Key Drivers
The key drivers of the Organ-on-Chip market are the increasing demand for organs for transplantation, the rising incidence of organ failure, and the need for alternative methods for testing drugs and cosmetics.
Organ-on-Chip technology offers a viable alternative to traditional animal testing, which is often inaccurate and expensive.
Additionally, Organ-on-Chip technology can be used to test the safety and efficacy of new drugs and cosmetics, which is a key driver of the market.
Restraints & Challenges
One of the key restraints in the Organ-on-Chip market is the lack of awareness about this technology. There is a need for more awareness about Organ-on-Chip technology and its potential applications in order to boost the market growth.
One of the challenges in the Organ-on-Chip market is the high cost of these devices. The high cost is a result of the complex manufacturing process and the need for specialized equipment.
Market Segments
The organ-on-chip market is segmented by type, application, end-user, and region. By type, the market is classified into liver, kidney, lung, and others. Based on application, it is bifurcated into toxicity testing, and physiological models. On the basis of the end-user, it is divided into an academic, research institute, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and the rest of the World.
Key Players
The organ-on-chip market includes players such as Mimetas, Emulate, InSphero, Ascendance Bio, CN Bio, TissUse GmbH, Kirkstall, Hurel, SynVivo, AxoSim, and others.
Table of Contents
Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Organ-on-Chip Market Outlook
3.1. Organ-on-Chip Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global Organ-on-Chip Market
Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global Organ-on-Chip Market
4.3. Economic Impact Analysis
Chapter 5. Organ-on-Chip Market by Application
5.1. Market Overview
5.2. Toxicity Testing
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Physiological Model
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Organ-on-Chip Market by End-User
6.1. Market Overview
6.2. Academic
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Research Institute
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Others
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Organ-on-Chip Market by Type
7.1. Market Overview
7.2. Liver
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Kidney
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Lung
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.5. Others
7.5.1. Market Size and Forecast, 2021-2031 ($Million)
7.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 8. Organ-on-Chip Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.2.3. North America Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.4. North America Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.5. North America Organ-on-Chip Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.2.6.2. The U.S. Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.6.3. The U.S. Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.2.7.2. Canada Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.7.3. Canada Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.2.8.2. Mexico Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.8.3. Mexico Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.3. Europe Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.4. Europe Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.5. Europe Organ-on-Chip Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.6.2. Germany Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.6.3. Germany Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.7.2. France Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.7.3. France Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.8.2. U.K. Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.8.3. U.K. Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.9.2. Spain Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.9.3. Spain Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.10.2. Italy Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.10.3. Italy Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Organ-on-Chip Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.4. Asia-Pacific Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.5. Asia-Pacific Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.6.2. China Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.6.3. China Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.7.2. India Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.7.3. India Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.8.2. Japan Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.8.3. Japan Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.9.2. South Korea Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.9.3. South Korea Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.5.3. Rest of the World Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.4. Rest of the World Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.5. Rest of the World Organ-on-Chip Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.5.6.2. Latin America Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.6.3. Latin America Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.5.7.2. Middle East Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.7.3. Middle East Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Organ-on-Chip Market Size and Forecast by Source, 2021-2031, ($Million)
8.5.8.2. Africa Organ-on-Chip Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.8.3. Africa Organ-on-Chip Market Size and Forecast by Type, 2021-2031, ($Million)
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions
Chapter 10. Company Profiles
10.1. Mimetas
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Emulate
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. InSphero
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Ascendance Bio
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. CN Bio
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. TissUse
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Kirkstall
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Hurel
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. SynVivo
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. AxoSim
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report
Key Players
Market Segmentation
By Type
- Liver
- Kidney
- Lung
- Others
By Application
- Toxicity Testing
- Physiological Model
- Others
By End-User
- Academic
- Research Institute
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
- Rest of the World
- Latin America
- Middle East
- Africa